Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Clofarabine and Low-dose Cytarabine in Older Patients with AML or MDS
NCT00839982Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Nov 2008
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by Fred Hutchinson Cancer Center. Started Nov 2008; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00839982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00839982.